Literature DB >> 19197219

Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.

Dima Suki1, Mustafa Aziz Hatiboglu, Akash J Patel, Jeffrey S Weinberg, Morris D Groves, Anita Mahajan, Raymond Sawaya.   

Abstract

OBJECTIVE: To test the hypothesis that differential risks of developing leptomeningeal disease (LMD) exist in patients having a single supratentorial brain metastasis resected via a piecemeal or en bloc approach or treated with stereotactic radiosurgery (SRS).
METHODS: Between 1993 and 2006, 827 patients with a supratentorial brain metastasis underwent resection or SRS at The University of Texas M.D. Anderson Cancer Center. The primary outcome was the incidence of LMD.
RESULTS: Resection was performed piecemeal in 191 patients and en bloc in 351 patients; 285 patients received SRS. LMD occurred in 33 patients, 29 in the resection group and 4 in the SRS group. Risk of LMD was significantly higher with piecemeal tumor resection than with other procedures (SRS: hazard ratio [HR] for piecemeal, 5.8; 95% confidence interval [CI], 1.9-17.2; P = 0.002; en bloc, HR for piecemeal, 2.7; 95% CI, 1.3-5.6; P = 0.009). The difference between piecemeal and en bloc was particularly pronounced in patients with a melanoma primary (HR, 8.4; 95% CI, 1.8-39.2; P = 0.007). The risk of LMD was not significantly different between en bloc resection and SRS (HR for en bloc, 2.1; 95% CI, 0.7-6.4; P = 0.21). Similar results were obtained when comparing effects of SRS and both resection approaches after limiting the sample to patients with tumors in a specific volume range.
CONCLUSION: Piecemeal resection of a supratentorial brain metastasis carries a higher risk of LMD than en bloc resection or SRS. Further assessment of the role of the 2 surgical resection approaches and SRS in a controlled prospective setting with large numbers of patients is warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19197219     DOI: 10.1227/01.NEU.0000341535.53720.3E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  39 in total

1.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

2.  Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.

Authors:  Kirtesh R Patel; Stuart H Burri; Danielle Boselli; James T Symanowski; Anthony L Asher; Ashley Sumrall; Robert W Fraser; Robert H Press; Jim Zhong; Richard J Cassidy; Jeffrey J Olson; Walter J Curran; Hui-Kuo G Shu; Ian R Crocker; Roshan S Prabhu
Journal:  J Neurooncol       Date:  2016-12-20       Impact factor: 4.130

3.  Commentary: The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.

Authors:  Michael Zhang; Gordon Li
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-08-28       Impact factor: 2.703

4.  When serendipity meets creativity.

Authors:  Masaaki Yamamoto
Journal:  J Radiosurg SBRT       Date:  2011

Review 5.  Single brain metastases from melanoma: remarks on a series of 84 patients.

Authors:  Maurizio Salvati; Alessandro Frati; Alessandro D'Elia; Lorenzo Pescatori; Manolo Piccirilli; Andrea Pietrantonio; Maurizio Fazi; Antonio Santoro
Journal:  Neurosurg Rev       Date:  2011-09-14       Impact factor: 3.042

Review 6.  Biology and therapy of neoplastic meningitis.

Authors:  Aaron G Mammoser; Morris D Groves
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

Review 7.  Neurosurgical management of patients with brain metastasis.

Authors:  Mustafa Aziz Hatiboglu; Kerime Akdur; Raymond Sawaya
Journal:  Neurosurg Rev       Date:  2018-07-29       Impact factor: 3.042

Review 8.  Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.

Authors:  Cristian Udovicich; Claire Phillips; David L Kok; Damien Tange; Nikki M Plumridge; Roshan S Prabhu; Neda Haghighi
Journal:  Curr Oncol Rep       Date:  2019-07-04       Impact factor: 5.075

9.  Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.

Authors:  Rosaline Ma; Morgan Levy; Bin Gui; Shou-En Lu; Venkat Narra; Sharad Goyal; Shabbar Danish; Simon Hanft; Atif J Khan; Jyoti Malhotra; Sabin Motwani; Salma K Jabbour
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

10.  Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease.

Authors:  Paul M Foreman; Bradford E Jackson; Karan P Singh; Andrew K Romeo; Barton L Guthrie; Winfield S Fisher; Kristen O Riley; James M Markert; Christopher D Willey; Markus Bredel; John B Fiveash
Journal:  J Clin Neurosci       Date:  2017-12-14       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.